Zegbeh Jallah
Stock Analyst at Capital One
(2.97)
# 1,295
Out of 4,814 analysts
25
Total ratings
34.78%
Success rate
111.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Zegbeh Jallah
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OTLK Outlook Therapeutics | Upgrades: Overweight | $100 | $1.47 | +6,702.72% | 2 | Dec 27, 2023 | |
| GLYC GlycoMimetics | Initiates: Overweight | $12 | $0.22 | +5,354.55% | 1 | Dec 22, 2023 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Overweight | $44 | $5.90 | +645.76% | 1 | Dec 11, 2023 | |
| KOD Kodiak Sciences | Upgrades: Overweight | n/a | $3.20 | - | 5 | Nov 17, 2023 | |
| IDYA IDEAYA Biosciences | Initiates: Overweight | $29 | $18.22 | +59.17% | 2 | Dec 28, 2022 | |
| RAPT RAPT Therapeutics | Initiates: Overweight | $48 | $0.78 | +6,052.27% | 2 | Sep 21, 2022 | |
| ENTA Enanta Pharmaceuticals | Maintains: Buy | $101 → $70 | $5.23 | +1,238.43% | 2 | May 12, 2022 | |
| RZLT Rezolute | Initiates: Buy | $21 | $3.14 | +568.79% | 1 | Sep 8, 2021 | |
| ARVN Arvinas | Maintains: Buy | $120 → $135 | $8.75 | +1,442.86% | 2 | Aug 9, 2021 | |
| DARE Daré Bioscience | Maintains: Buy | $108 → $132 | $2.97 | +4,344.44% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $6 | $0.68 | +782.35% | 2 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $55 | $12.07 | +355.68% | 1 | Feb 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $3.61 | - | 1 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.80 | +900.00% | 1 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $0.19 | +10,618.11% | 1 | Dec 18, 2019 |
Outlook Therapeutics
Dec 27, 2023
Upgrades: Overweight
Price Target: $100
Current: $1.47
Upside: +6,702.72%
GlycoMimetics
Dec 22, 2023
Initiates: Overweight
Price Target: $12
Current: $0.22
Upside: +5,354.55%
EyePoint Pharmaceuticals
Dec 11, 2023
Initiates: Overweight
Price Target: $44
Current: $5.90
Upside: +645.76%
Kodiak Sciences
Nov 17, 2023
Upgrades: Overweight
Price Target: n/a
Current: $3.20
Upside: -
IDEAYA Biosciences
Dec 28, 2022
Initiates: Overweight
Price Target: $29
Current: $18.22
Upside: +59.17%
RAPT Therapeutics
Sep 21, 2022
Initiates: Overweight
Price Target: $48
Current: $0.78
Upside: +6,052.27%
Enanta Pharmaceuticals
May 12, 2022
Maintains: Buy
Price Target: $101 → $70
Current: $5.23
Upside: +1,238.43%
Rezolute
Sep 8, 2021
Initiates: Buy
Price Target: $21
Current: $3.14
Upside: +568.79%
Arvinas
Aug 9, 2021
Maintains: Buy
Price Target: $120 → $135
Current: $8.75
Upside: +1,442.86%
Daré Bioscience
Jun 30, 2021
Maintains: Buy
Price Target: $108 → $132
Current: $2.97
Upside: +4,344.44%
Jun 11, 2021
Downgrades: Neutral
Price Target: $10 → $6
Current: $0.68
Upside: +782.35%
Feb 18, 2021
Maintains: Buy
Price Target: $30 → $55
Current: $12.07
Upside: +355.68%
Aug 5, 2020
Initiates: Buy
Price Target: n/a
Current: $3.61
Upside: -
May 13, 2020
Initiates: Buy
Price Target: $8
Current: $0.80
Upside: +900.00%
Dec 18, 2019
Initiates: Buy
Price Target: $20
Current: $0.19
Upside: +10,618.11%